Author Correction: Targeting public neoantigens for cancer immunotherapy

AmendmenTs https://doi.org/10.1038/s43018-021-00246-0 Author Correction: Targeting public neoantigens for cancer immunotherapy Alexander H. Pearlman , Michael S. Hwang, Maximilian F. Konig , Emily Han-Chung Hsiue, Jacqueline Douglass, Sarah R. DiNapoli, Brian J. Mog , Chetan Bettegowda, Drew M. Pardoll, Sandra B. Gabelli, Nicholas Papadopoulos , Kenneth W. Kinzler, Bert Vogelstein and Shibin Zhou Correction to: Nature Cancer https://doi.org/10.1038/s43018-021-00210-y, published online 17 May 2021. In the version of this article initially published, the seventh label along the vertical axis of Fig. 3 (IDH1 p.Arg132Cys) was incorrect, and ten labels (TCGA project names) along the horizontal axis of Fig. 3 were not in the correct order. The correct label along the vertical axis is ‘KRAS p.Gly12Cys’, and the correct order for labels along the horizontal axis is now provided. The errors have been corrected in the HTML and PDF versions of the article. Nature Cancer | VOL 2 | August 2021 | 865–867 | www.nature.com/natcancer 865 AmendmenTs Nature Cancer Original BRAF p.Val600Glu BRAF p.Val600Met FBXW7 p.Arg465Cys FBXW7 p.Arg479Gln FGFR3 p.Ser249Cys IDH1 p.Arg132Cys IDH1 p.Arg132Cys KRAS p.Gly12Asp KRAS p.Gly12Arg KRAS p.Gly12Val KRAS p.Gly13Asp Percent Alteration MUC4 p.Asp3157Asn 60 NRAS p.Gln61Lys 40 NRAS p.Gln61Arg 20 PIK3CA p.Glu545Lys 0 PIK3CA p.His1047Arg PIK3CA p.Arg88Gln PPP2R1A p.Pro179Arg PTEN p.Arg130Gly PTEN p.Arg130Gln TP53 p.Arg175His TP53 p.Arg248Gln TP53 p.Arg273His TP53 p.Arg282Trp TP53 p.Ser241Tyr st ea de ad Bl Br ru ro th el ia l in va car ci si no v C e m ho ca a la rc H C ng in ea ol om io d on ca an a ad r d en cino ne K o m ck id ca a ne s rc Ki y in dn qua c o h m m ey ou rom a re s na ce oph lc l o l be le ca ar r ce cin Lu Li om ve ll ng Ki ca r a dn rc ey hep ade no inom at re ac ca na a el rc lp in ap lula om rc illa Pa a ar ry n ce cino Lu cre at ll ng m ca i a sq c a rc de ua i no nom m a Pr ous carc os ce in o ta ll m te ca a ad rc R ec in en o tu m o m ca a ad rc in en o m Th oca Sk a rc y in in cu roid U o m te ta a rin ne car ci U e ou no te co s rin m rp m a e el us ca an en rc om in do os a m ar et co ria m lc a ar ci no m a Sum TCGA project 866 Nature Cancer | VOL 2 | August 2021 | 865–867 | www.nature.com/natcancer AmendmenTs Nature Cancer Corrected BRAF p.Val600Glu BRAF p.Val600Met FBXW7 p.Arg465Cys FBXW7 p.Arg479Gln FGFR3 p.Ser249Cys IDH1 p.Arg132Cys KRAS p.Gly12Cys KRAS p.Gly12Asp KRAS p.Gly12Arg KRAS p.Gly12Val KRAS p.Gly13Asp Percent Alteration MUC4 p.Asp3157Asn 60 NRAS p.Gln61Lys 40 NRAS p.Gln61Arg 20 PIK3CA p.Glu545Lys 0 PIK3CA p.His1047Arg PIK3CA p.Arg88Gln PPP2R1A p.Pro179Arg PTEN p.Arg130Gly PTEN p.Arg130Gln TP53 p.Arg175His TP53 p.Arg248Gln TP53 p.Arg273His TP53 p.Arg282Trp TP53 p.Ser241Tyr st ea dd Bl a Br er ur ot he lia l in va car H ci si ea no v e C d m ho ca an a rc la d ng in C ne o o io ck lo m ca a sq n a rc d ua in om m eno ou ca a s Ki ce rcin dn K o l lc Ki ey id m dn ne ar a ci ey ren y no al ch re m ro na cle a m ar lp ce oph ap Li ve ob ll illa ca rh e rc ep r y c in el at o l m ac ca a el r Lu Lu lula cino ng r ng m ca a sq ad r ua en cin o oc m Pa mo a ar u nc re s ce cin om at l l ca a Pr ic a rc de os no inom ta te ca a R rc ec ade no inom tu ca Sk m a a rc de in in U n c om ut oc te an rin a ar eo ci e no co us m rp m Th a us el an en yro id om do ca m a rc et U in r te om rin ial ca e a rc ca in rc om in os a ar co m a Sum TCGA project Fig. 3 | Original and corrected. Published online: 29 July 2021 https://doi.org/10.1038/s43018-021-00246-0 © Springer Nature America, Inc. 2021 Nature Cancer | VOL 2 | August 2021 | 865–867 | www.nature.com/natcancer 867  (...truncated)